ReviewHepatology international2015
The gut microbiota of nonalcoholic fatty liver disease: current methods and their interpretation.
Review in Hepatology international, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 36 citations in OpenAlex.
- The Intestinal Microbiota in the Development of Chronic Liver Disease: Current Status.Diagnostics (Basel, Switzerland) · 2023Review
- Faeces-derived extracellular vesicles participate in the onset of barrier dysfunction leading to liver diseases.Journal of extracellular vesicles · 2023Article
- Gut microbiota in non-alcoholic fatty liver disease and alcohol-related liver disease: Current concepts and perspectives.Hepatology research : the official journal of the Japan Society of Hepatology · 2020Review
- Dietary fiber and chicken microbiome interaction: Where will it lead to?Animal nutrition (Zhongguo xu mu shou yi xue hui) · 2020Review
- Function ofFrontiers in microbiology · 2020Review
- Gut-liver axis, cirrhosis and portal hypertension: the chicken and the egg.Hepatology international · 2018Article
- The Association of Gut Microbiota with Nonalcoholic Steatohepatitis in Thais.BioMed research international · 2018Article
- Bile acids and nonalcoholic fatty liver disease: Molecular insights and therapeutic perspectives.Hepatology (Baltimore, Md.) · 2017Review
- PBHMDA: Path-Based Human Microbe-Disease Association Prediction.Frontiers in microbiology · 2017Article
- Article
- The Janus-Face of Bacteriophages across Human Body Habitats.PLoS pathogens · 2016Review
- Gastrointestinal dysbiosis and the use of fecal microbial transplantation in Clostridium difficile infection.World journal of gastrointestinal pathophysiology · 2015Review
- Library preparation methodology can influence genomic and functional predictions in human microbiome research.Proceedings of the National Academy of Sciences of the United States of America · 2015Article
- Gut Microbiota and Host Reaction in Liver Diseases.Microorganisms · 2015Review
- Gut Microbiota Profiles in Nonalcoholic Fatty Liver Disease and Its Possible Impact on Disease Progression Evaluated with Transient Elastography: Lesson Learnt from 60 Cases.Case reports in gastroenterologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The role of intestinal bacteria in the pathogenesis of nonalcoholic fatty liver disease is increasingly acknowledged. Recently developed microbial profiling techniques are beginning to shed light on the nature of gut microbiota alterations in nonalcoholic fatty liver disease. In this review, we summarize the gut microbiota composition changes that have been reported during different stages of human nonalcoholic fatty liver disease, and highlight the relation between bile acids and gut bacteria in this context. In addition, we discuss the different methodologies used in microbiota analyses as well as the interpretation of microbiota data. Whereas the currently available studies have provided useful information, future large-scale prospective studies with carefully phenotyped subjects and sequential sampling will be required to demonstrate a causal role of gut microbiota changes in the etiology of nonalcoholic fatty liver disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.